GRACO INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that GRACO INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 26, 2025 | $2.24B | Feb 17, 2026 |
| FY2025 | Dec 27, 2024 | $2.11B | Feb 17, 2026 |
| FY2025 | Dec 29, 2023 | $2.20B | Feb 17, 2026 |
| FY2024 | Dec 30, 2022 | $2.14B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $1.99B | Feb 20, 2024 |
| FY2020 | Dec 25, 2020 | $470.34M | Feb 16, 2021 |
| FY2020 | Sep 25, 2020 | $439.32M | Feb 16, 2021 |
| FY2020 | Jun 26, 2020 | $366.89M | Feb 16, 2021 |
| FY2020 | Mar 27, 2020 | $373.57M | Feb 16, 2021 |
| FY2020 | Dec 27, 2019 | $412.29M | Feb 16, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 29, 2017 | $374.86M | Apr 23, 2018 |
| FY2017 | Sep 29, 2017 | $379.81M | Apr 23, 2018 |
| FY2017 | Jun 30, 2017 | $379.48M | Apr 23, 2018 |
| FY2017 | Mar 31, 2017 | $340.59M | Apr 23, 2018 |
| FY2017 | Dec 30, 2016 | $349.06M | Apr 23, 2018 |
| FY2017 | Sep 23, 2016 | $327.19M | Apr 23, 2018 |
| FY2017 | Jun 24, 2016 | $348.13M | Apr 23, 2018 |
| FY2017 | Mar 25, 2016 | $304.91M | Apr 23, 2018 |
| FY2016 | Dec 25, 2015 | $325.56M | Feb 21, 2017 |
| FY2016 | Sep 25, 2015 | $318.99M | Feb 21, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 26, 2025 | $1.17B | Feb 17, 2026 |
| FY2025 | Dec 27, 2024 | $1.12B | Feb 17, 2026 |
| FY2025 | Dec 29, 2023 | $1.16B | Feb 17, 2026 |
| FY2024 | Dec 30, 2022 | $1.06B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $1.03B | Feb 20, 2024 |
| FY2020 | Dec 25, 2020 | $244.82M | Feb 16, 2021 |
| FY2020 | Sep 25, 2020 | $228.95M | Feb 16, 2021 |
| FY2020 | Jun 26, 2020 | $182.53M | Feb 16, 2021 |
| FY2020 | Mar 27, 2020 | $198.63M | Feb 16, 2021 |
| FY2020 | Dec 27, 2019 | $209.38M | Feb 16, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 26, 2025 | $521.84M | Feb 17, 2026 |
| FY2025 | Dec 27, 2024 | $486.08M | Feb 17, 2026 |
| FY2025 | Dec 29, 2023 | $506.51M | Feb 17, 2026 |
| FY2024 | Dec 30, 2022 | $460.65M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $439.87M | Feb 20, 2024 |
| FY2022 | Dec 25, 2020 | $330.46M | Feb 21, 2023 |
| FY2021 | Dec 27, 2019 | $343.85M | Feb 22, 2022 |
| FY2020 | Dec 28, 2018 | $341.05M | Feb 16, 2021 |
| FY2019 | Dec 29, 2017 | $252.41M | Feb 18, 2020 |
| FY2018 | Dec 30, 2016 | $40.67M | Feb 19, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 26, 2025 | $624.80M | Feb 17, 2026 |
| FY2025 | Dec 27, 2024 | $570.10M | Feb 17, 2026 |
| FY2025 | Dec 29, 2023 | $646.84M | Feb 17, 2026 |
| FY2024 | Dec 30, 2022 | $572.70M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $531.32M | Feb 20, 2024 |
| FY2022 | Dec 25, 2020 | $391.72M | Feb 21, 2023 |
| FY2021 | Dec 27, 2019 | $424.46M | Feb 22, 2022 |
| FY2020 | Dec 28, 2018 | $436.43M | Feb 16, 2021 |
| FY2019 | Dec 29, 2017 | $378.75M | Feb 18, 2020 |
| FY2018 | Dec 30, 2016 | $121.14M | Feb 19, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 26, 2025 | $82.30M | Feb 17, 2026 |
| FY2025 | Dec 27, 2024 | $87.23M | Feb 17, 2026 |
| FY2025 | Dec 29, 2023 | $82.82M | Feb 17, 2026 |
| FY2024 | Dec 30, 2022 | $80.01M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $79.65M | Feb 20, 2024 |
| FY2022 | Dec 25, 2020 | $72.19M | Feb 21, 2023 |
| FY2021 | Dec 27, 2019 | $67.56M | Feb 22, 2022 |
| FY2020 | Dec 28, 2018 | $63.12M | Feb 16, 2021 |
| FY2019 | Dec 29, 2017 | $59.22M | Feb 18, 2020 |
| FY2018 | Dec 30, 2016 | $59.57M | Feb 19, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 26, 2025 | $683.59M | Feb 17, 2026 |
| FY2025 | Dec 27, 2024 | $621.70M | Feb 17, 2026 |
| FY2025 | Dec 29, 2023 | $651.02M | Feb 17, 2026 |
| FY2024 | Dec 30, 2022 | $377.39M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $456.90M | Feb 20, 2024 |
| FY2022 | Dec 25, 2020 | $394.04M | Feb 21, 2023 |
| FY2021 | Dec 27, 2019 | $418.73M | Feb 22, 2022 |
| FY2020 | Dec 28, 2018 | $367.99M | Feb 16, 2021 |
| FY2019 | Dec 29, 2017 | $337.86M | Feb 18, 2020 |
| FY2018 | Dec 30, 2016 | $276.01M | Feb 19, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 26, 2025 | $45.67M | Feb 17, 2026 |
| FY2025 | Dec 27, 2024 | $106.74M | Feb 17, 2026 |
| FY2025 | Dec 29, 2023 | $184.78M | Feb 17, 2026 |
| FY2024 | Dec 30, 2022 | $201.16M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $133.57M | Feb 20, 2024 |
| FY2022 | Dec 25, 2020 | $71.34M | Feb 21, 2023 |
| FY2021 | Dec 27, 2019 | $127.95M | Feb 22, 2022 |
| FY2020 | Dec 28, 2018 | $53.85M | Feb 16, 2021 |
| FY2019 | Dec 29, 2017 | $40.19M | Feb 18, 2020 |
| FY2018 | Dec 30, 2016 | $42.11M | Feb 19, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 26, 2025 | $3.27B | Feb 17, 2026 |
| FY2025 | Dec 27, 2024 | $3.14B | Feb 17, 2026 |
| FY2024 | Dec 29, 2023 | $2.72B | Feb 18, 2025 |
| FY2023 | Dec 30, 2022 | $2.44B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $2.44B | Feb 21, 2023 |
| FY2021 | Dec 25, 2020 | $1.99B | Feb 22, 2022 |
| FY2020 | Dec 27, 2019 | $1.69B | Feb 16, 2021 |
| FY2019 | Dec 28, 2018 | $1.47B | Feb 18, 2020 |
| FY2018 | Dec 29, 2017 | $1.39B | Feb 19, 2019 |
| FY2017 | Dec 30, 2016 | $1.24B | Apr 23, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 26, 2025 | $2.65B | Feb 17, 2026 |
| FY2025 | Dec 27, 2024 | $2.58B | Feb 17, 2026 |
| FY2025 | Dec 29, 2023 | $2.22B | Feb 17, 2026 |
| FY2025 | Dec 30, 2022 | $1.86B | Feb 17, 2026 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 26, 2025 | $585.30M | Feb 17, 2026 |
| FY2025 | Dec 27, 2024 | $487.47M | Feb 17, 2026 |
| FY2025 | Dec 29, 2023 | $370.23M | Feb 17, 2026 |
| FY2024 | Dec 30, 2022 | $368.17M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $356.26M | Feb 20, 2024 |
| FY2022 | Dec 25, 2020 | $347.60M | Feb 21, 2023 |
| FY2021 | Dec 27, 2019 | $307.66M | Feb 22, 2022 |
| FY2020 | Dec 28, 2018 | $293.85M | Feb 16, 2021 |
| FY2019 | Dec 29, 2017 | $278.79M | Feb 18, 2020 |
| FY2018 | Dec 30, 2016 | $259.85M | Feb 19, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 26, 2025 | $1.46B | Feb 17, 2026 |
| FY2025 | Dec 27, 2024 | $1.51B | Feb 17, 2026 |
| FY2024 | Dec 29, 2023 | $1.23B | Feb 18, 2025 |
| FY2023 | Dec 30, 2022 | $976.85M | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $876.92M | Feb 21, 2023 |
| FY2021 | Dec 25, 2020 | $568.30M | Feb 22, 2022 |
| FY2020 | Dec 27, 2019 | $448.99M | Feb 16, 2021 |
| FY2019 | Dec 28, 2018 | $220.73M | Feb 18, 2020 |
| FY2018 | Dec 29, 2017 | $181.60M | Feb 19, 2019 |
| FY2017 | Dec 30, 2016 | $206.82M | Apr 23, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 26, 2025 | $624.08M | Feb 17, 2026 |
| FY2025 | Dec 27, 2024 | $675.34M | Feb 17, 2026 |
| FY2024 | Dec 29, 2023 | $537.95M | Feb 18, 2025 |
| FY2023 | Dec 30, 2022 | $339.20M | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $624.30M | Feb 21, 2023 |
| FY2021 | Dec 25, 2020 | $378.91M | Feb 22, 2022 |
| FY2020 | Dec 27, 2019 | $220.97M | Feb 16, 2021 |
| FY2019 | Dec 28, 2018 | $132.12M | Feb 18, 2020 |
| FY2019 | Dec 29, 2017 | $103.66M | Feb 18, 2020 |
| FY2018 | Dec 30, 2016 | $52.37M | Feb 19, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 26, 2025 | 3 | Feb 17, 2026 |
| FY2025 | Dec 27, 2024 | 2 | Feb 17, 2026 |
| FY2025 | Dec 29, 2023 | 3 | Feb 17, 2026 |
| FY2024 | Dec 30, 2022 | 2 | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 20, 2024 |
| FY2020 | Dec 25, 2020 | 0 | Feb 16, 2021 |
| FY2020 | Sep 25, 2020 | 0 | Feb 16, 2021 |
| FY2020 | Jun 26, 2020 | 0 | Feb 16, 2021 |
| FY2020 | Mar 27, 2020 | 0 | Feb 16, 2021 |
| FY2020 | Dec 27, 2019 | 0 | Feb 16, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 26, 2025 | 3 | Feb 17, 2026 |
| FY2025 | Dec 27, 2024 | 2 | Feb 17, 2026 |
| FY2025 | Dec 29, 2023 | 2 | Feb 17, 2026 |
| FY2024 | Dec 30, 2022 | 2 | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 20, 2024 |
| FY2020 | Dec 25, 2020 | 0 | Feb 16, 2021 |
| FY2020 | Sep 25, 2020 | 0 | Feb 16, 2021 |
| FY2020 | Jun 26, 2020 | 0 | Feb 16, 2021 |
| FY2020 | Mar 27, 2020 | 0 | Feb 16, 2021 |
| FY2020 | Dec 27, 2019 | 0 | Feb 16, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 26, 2025 | 165.15M | Feb 17, 2026 |
| FY2025 | Dec 27, 2024 | 169.39M | Feb 17, 2026 |
| FY2024 | Dec 29, 2023 | 167.95M | Feb 18, 2025 |
| FY2023 | Dec 30, 2022 | 167.70M | Feb 20, 2024 |
| FY2022 | Jul 1, 2022 | 169.13M | Feb 21, 2023 |
| FY2021 | Jun 25, 2021 | 169.66M | Feb 22, 2022 |
| FY2019 | Dec 27, 2019 | 167.29M | Feb 18, 2020 |
| FY2019 | Dec 28, 2018 | 165.17M | Feb 18, 2020 |
| FY2018 | Dec 29, 2017 | 169.32M | Feb 19, 2019 |
| FY2017 | Dec 30, 2016 | 167.50M | Apr 23, 2018 |